• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术者经验和手术量对左主干经皮冠状动脉介入治疗结局的影响。

Impact of Operator Experience and Volume on Outcomes After Left Main Coronary Artery Percutaneous Coronary Intervention.

机构信息

Fu Wai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences, Beijing, China.

Cardiovascular Research Foundation, New York, New York; Sahlgrenska University Hospital, Gothenburg, Sweden.

出版信息

JACC Cardiovasc Interv. 2016 Oct 24;9(20):2086-2093. doi: 10.1016/j.jcin.2016.08.011.

DOI:10.1016/j.jcin.2016.08.011
PMID:27765302
Abstract

OBJECTIVES

The aim of this study was to assess the impact of operator experience on prognosis after left main coronary artery (LM) percutaneous coronary intervention (PCI).

BACKGROUND

LM PCI can be technically challenging and potentially risky considering the amount of supplied myocardium.

METHODS

Consecutive patients who underwent unprotected LM PCI at a single institution were included and compared according to whether the primary operator was an experienced, high-volume LM operator (defined as an operator who performed at least 15 LM PCIs per year for at least 3 consecutive years) or not. Kaplan-Meier estimates and Cox proportional hazards models are presented.

RESULTS

From January 2004 to December 2011, a total of 1,948 patients underwent unprotected LM PCI by 25 operators. Of these, 7 operators (28%) were considered experienced, and 18 (72%) were considered less experienced, with an overall mean experience of 12.0 ± 11.5 LM PCIs per year. LM PCI was performed in 1,422 patients (73%) by experienced operators and in 526 patients (27%) by less experienced operators. Patients treated by experienced operators had more complex and extensive coronary artery disease. Unadjusted and adjusted risks for cardiac death were lower for patients who were treated by experienced operators, both at 30-day (unadjusted hazard ratio [HR]: 0.23; 95% confidence interval [CI]: 0.09 to 0.60; p = 0.003; adjusted HR: 0.22; 95% CI: 0.09 to 0.59; p = 0.003) and 3-year (unadjusted HR: 0.53; 95% CI: 0.32 to 0.89, p = 0.02; adjusted HR: 0.49; 95% CI: 0.29 to 0.84; p = 0.009) follow-up. Discrimination improved when operator experience was added to Cox proportional hazards models containing the SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery) score (integrated discriminatory index = 0.004, p = 0.03) or SYNTAX score II (integrated discriminatory index = 0.007, p = 0.02). No significant interaction was detected between operator experience and distal bifurcation LM lesion, 2-stent bifurcation stenting, and intravascular ultrasound use (p > 0.10 for all).

CONCLUSIONS

Patients who underwent LM PCI by high-volume and experienced operators had better short- and long-term prognoses. Operator experience is an important factor in a complex intervention such as LM PCI.

摘要

目的

本研究旨在评估术者经验对左主干(LM)经皮冠状动脉介入治疗(PCI)后预后的影响。

背景

考虑到供应心肌的数量,LM PCI 技术上具有挑战性且潜在风险较大。

方法

连续纳入在一家机构接受非保护 LM PCI 的患者,并根据主要术者是否为经验丰富、高容量 LM 术者(定义为每年至少进行 15 例 LM PCI 且至少连续 3 年)进行比较。Kaplan-Meier 估计和 Cox 比例风险模型用于评估。

结果

2004 年 1 月至 2011 年 12 月,共有 1948 例患者由 25 名术者行非保护 LM PCI。其中,7 名术者(28%)被认为是经验丰富的术者,18 名术者(72%)为经验较少的术者,总体平均每年 LM PCI 经验为 12.0±11.5 例。1422 例患者(73%)由经验丰富的术者治疗,526 例患者(27%)由经验较少的术者治疗。经验丰富的术者治疗的患者冠状动脉疾病更复杂和广泛。未校正和校正后的 30 天(未校正风险比[HR]:0.23;95%置信区间[CI]:0.09 至 0.60;p=0.003;校正 HR:0.22;95%CI:0.09 至 0.59;p=0.003)和 3 年(未校正 HR:0.53;95%CI:0.32 至 0.89,p=0.02;校正 HR:0.49;95%CI:0.29 至 0.84;p=0.009)随访的心脏死亡风险较低。当术者经验被加入到包含 SYNTAX(紫杉醇与心脏手术的协同作用)评分(综合鉴别指数=0.004,p=0.03)或 SYNTAX 评分 II(综合鉴别指数=0.007,p=0.02)的 Cox 比例风险模型中时,区分度提高。术者经验与远端分叉 LM 病变、双支架分叉支架置入术和血管内超声应用之间无显著交互作用(p>0.10)。

结论

由高容量、经验丰富的术者行 LM PCI 的患者具有更好的短期和长期预后。术者经验是 LM PCI 等复杂介入治疗的重要因素。

相似文献

1
Impact of Operator Experience and Volume on Outcomes After Left Main Coronary Artery Percutaneous Coronary Intervention.术者经验和手术量对左主干经皮冠状动脉介入治疗结局的影响。
JACC Cardiovasc Interv. 2016 Oct 24;9(20):2086-2093. doi: 10.1016/j.jcin.2016.08.011.
2
Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).三维分叉角度对左主干冠状动脉疾病经皮冠状动脉介入治疗后 5 年预后的影响:SYNTAX 试验(紫杉醇药物洗脱支架与心脏搭桥术的联合治疗)的一项亚组研究。
JACC Cardiovasc Interv. 2013 Dec;6(12):1250-60. doi: 10.1016/j.jcin.2013.08.009.
3
The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study.基于解剖和临床的 NERS(新风险分层)评分 II 预测无保护左主干冠状动脉疾病支架置入后的临床结局:来自多中心、前瞻性登记研究的结果。
JACC Cardiovasc Interv. 2013 Dec;6(12):1233-41. doi: 10.1016/j.jcin.2013.08.006. Epub 2013 Nov 13.
4
Coronary Artery Bypass Graft Surgery and Percutaneous Coronary Interventions in Patients With Unprotected Left Main Coronary Artery Disease.冠状动脉旁路移植术与经皮冠状动脉介入治疗在无保护左主干冠状动脉疾病患者中的应用。
JACC Cardiovasc Interv. 2016 Jun 13;9(11):1102-11. doi: 10.1016/j.jcin.2016.03.039.
5
Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.经皮冠状动脉介入治疗开口/中段病变与无保护左主干冠状动脉分叉病变的长期临床结局:DELTA 注册研究(左主干冠状动脉疾病药物洗脱支架):一项多中心注册研究,评估经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗左主干的疗效。
JACC Cardiovasc Interv. 2013 Dec;6(12):1242-9. doi: 10.1016/j.jcin.2013.08.005.
6
Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.DELTA 注册研究:非保护左主干冠状动脉开口/中段病变行经皮冠状动脉介入治疗与冠状动脉旁路移植术的长期临床结果:多中心注册研究评估左主干病变的经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗
JACC Cardiovasc Interv. 2014 Apr;7(4):354-61. doi: 10.1016/j.jcin.2013.11.014. Epub 2014 Mar 14.
7
Validation and comparison of the long-term prognostic capability of the SYNTAX score-II among 1,528 consecutive patients who underwent left main percutaneous coronary intervention.SYNTAX score-II 对 1528 例行左主干经皮冠状动脉介入治疗患者的长期预后能力的验证和比较。
JACC Cardiovasc Interv. 2014 Oct;7(10):1128-37. doi: 10.1016/j.jcin.2014.05.018. Epub 2014 Sep 17.
8
Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.药物洗脱支架置入治疗无保护左主干冠状动脉疾病后,冠状动脉解剖结构和支架技术对长期预后的影响。
JACC Cardiovasc Interv. 2014 Jan;7(1):29-36. doi: 10.1016/j.jcin.2013.08.013. Epub 2013 Dec 11.
9
The DELTA 2 Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents in Patients With Obstructive Left Main Coronary Artery Disease.DELTA 2 注册研究:一项多中心注册研究,旨在评估新型药物洗脱支架经皮冠状动脉介入治疗伴左主干病变的患者。
JACC Cardiovasc Interv. 2017 Dec 11;10(23):2401-2410. doi: 10.1016/j.jcin.2017.08.050.
10
Major Predictors of Long-Term Clinical Outcomes After Percutaneous Coronary Intervention for Coronary Bifurcation Lesions With 2-Stent Strategy: Patient-Level Analysis of the Korean Bifurcation Pooled Cohorts.经皮冠状动脉介入治疗冠状动脉分叉病变双支架策略的长期临床结局的主要预测因素:韩国分叉队列的患者水平分析。
JACC Cardiovasc Interv. 2016 Sep 26;9(18):1879-86. doi: 10.1016/j.jcin.2016.06.049. Epub 2016 Aug 31.

引用本文的文献

1
Late left main sub-total occlusion after surgical aortic valve replacement.主动脉瓣置换术后晚期左主干次全闭塞。
Kardiochir Torakochirurgia Pol. 2025 Jun 24;22(2):137-148. doi: 10.5114/kitp.2025.152366. eCollection 2025 Jun.
2
The First-in-Man Technique of Drug Eluting and Perfusion Therapy for Left Main Coronary Artery Disease.左主干冠状动脉疾病的药物洗脱与灌注治疗的首例人体技术。
Catheter Cardiovasc Interv. 2025 Aug;106(2):978-987. doi: 10.1002/ccd.31621. Epub 2025 May 29.
3
Assessment of acute coronary syndromes among patients with left main coronary artery disease in centers with and without cardiac surgery on-site. Data from PL-ACS registry.
在有和没有现场心脏手术的中心评估左主干冠状动脉疾病患者的急性冠状动脉综合征。来自波兰急性冠状动脉综合征(PL-ACS)注册研究的数据。
Cardiol J. 2025;32(3):278-290. doi: 10.5603/cj.98087. Epub 2025 May 21.
4
Retrospective Analysis of the Thai Percutaneous Coronary Intervention Registry: Impacts of Center Volume and Operator Experience on Outcomes.泰国经皮冠状动脉介入治疗注册研究的回顾性分析:中心手术量和术者经验对治疗结果的影响
Catheter Cardiovasc Interv. 2025 Feb;105(2):442-455. doi: 10.1002/ccd.31334. Epub 2024 Dec 10.
5
Mechanical Circulatory Support for Complex High-risk Percutaneous Coronary Intervention.复杂高危经皮冠状动脉介入治疗的机械循环支持
US Cardiol. 2023 Apr 4;17:e03. doi: 10.15420/usc.2022.26. eCollection 2023.
6
PCI in Patients With Heart Failure: Current Evidence, Impact of Complete Revascularization, and Contemporary Techniques to Improve Outcomes.心力衰竭患者的经皮冠状动脉介入治疗:当前证据、完全血运重建的影响及改善预后的当代技术
J Soc Cardiovasc Angiogr Interv. 2022 Apr 11;1(2):100020. doi: 10.1016/j.jscai.2022.100020. eCollection 2022 Mar-Apr.
7
See One, Do One, Teach One? Not So Fast, My Friend.看一个,做一个,教一个?没那么快,我的朋友。
J Soc Cardiovasc Angiogr Interv. 2022 Apr 15;1(3):100311. doi: 10.1016/j.jscai.2022.100311. eCollection 2022 May-Jun.
8
Intracoronary Imaging of Proximal Coronary Artery Lesions A Nationwide Lesion-Level Analysis From SCAAR.冠状动脉近端病变的冠状动脉内成像:来自SCAAR的全国性病变水平分析
J Soc Cardiovasc Angiogr Interv. 2023 Feb 20;2(3):100597. doi: 10.1016/j.jscai.2023.100597. eCollection 2023 May-Jun.
9
Technological Advances Are Associated With Better Clinical Outcomes of Percutaneous Coronary Intervention in Patients With Unprotected Left Main Disease.技术进步与无保护左主干病变患者经皮冠状动脉介入治疗的临床结局改善相关。
J Am Heart Assoc. 2024 Aug 20;13(16):e033929. doi: 10.1161/JAHA.123.033929. Epub 2024 Aug 9.
10
Feasibility and Safety of Drug-Coated Balloon for Treatment of Coronary Artery Lesions in Large Vessel Disease: A Large-Scale Multicenter Prospective Study.药物涂层球囊治疗大血管病变冠状动脉狭窄的可行性及安全性:一项大规模多中心前瞻性研究
Rev Cardiovasc Med. 2023 Oct 7;24(10):277. doi: 10.31083/j.rcm2410277. eCollection 2023 Oct.